SeaStar Medical Holding ICU
NASDAQ ICU
$3.35 +0.01 (+0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

SeaStar Medical Holding (ICU) Change in Account Payables (2022 - 2026)

SeaStar Medical Holding's (ICU) quarterly Change in Account Payables came in at -$229000.0 in Q1 2026, down 165.24% YoY from $351000.0 in Q1 2025, and up 78.6% on a QoQ basis from -$1.1 million in Q4 2025.

SeaStar Medical Holding (ICU) Change in Account Payables (2022 - 2026) Analysis & Trends

SeaStar Medical Holding (ICU) has 5 years of Change in Account Payables data on file, last reported at -$229000.0 in Q1 2026.

  • Quarterly Change in Account Payables fell 165.24% year-over-year to -$229000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.7 million (down 512.81% YoY) and the FY2025 annual result came in at -$2.1 million, down 63.78% from the prior year.
  • Change in Account Payables climbed to -$229000.0 in Q1 2026, from -$1.1 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.1 million in Q4 2022 to a low of -$1.1 million in Q3 2025.
  • A 5-year average of $24062.5 and a median of -$234000.0 in 2025 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2023 — Change in Account Payables surged 860.53% — and 2025, when it plunged 200.42%.
  • Tracing ICU's Change in Account Payables over 5 years: stood at $2.1 million in 2022, then tumbled by 131.51% to -$670000.0 in 2023, then surged by 36.87% to -$423000.0 in 2024, then tumbled by 152.96% to -$1.1 million in 2025, then soared by 78.6% to -$229000.0 in 2026.
  • The last three Change in Account Payables figures came in at -$229000.0 (Q1 2026), -$1.1 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 SeaStar Medical Holding 13.68 Mn 6.68 Mn 561,000.00 31,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 31,000.00
Jun 30, 2026 31,000.00
Mar 31, 2026 -229,000.00
Mar 31, 2026 -229,000.00
Dec 31, 2025 -1.07 Mn
Dec 31, 2025 -1.07 Mn
Sep 30, 2025 -1.14 Mn
Sep 30, 2025 -1.14 Mn
Jun 30, 2025 -239,000.00
Jun 30, 2025 -239,000.00
Mar 31, 2025 351,000.00
Mar 31, 2025 351,000.00
Dec 31, 2024 -423,000.00
Dec 31, 2024 -423,000.00
Sep 30, 2024 -603,000.00
Sep 30, 2024 -603,000.00
Jun 30, 2024 238,000.00
Jun 30, 2024 238,000.00
Mar 31, 2024 -493,000.00
Mar 31, 2024 -493,000.00